BACKGROUND: Body weight is associated with colorectal cancer (CRC) risk and survival, but to the authors' knowledge, the impact of long-term postdiagnostic weight change is unclear. Herein, the authors investigated whether weight change over the 5 years after a diagnosis of CRC is associated with survival. METHODS: CRC cases diagnosed from 1997 to 2008 were identified through 4 population-based cancer registry sites. Participants enrolled within 2 years of diagnosis and reported their height and weight 2 years prior. Follow-up questionnaires were administered approximately 5 years after diagnosis. Associations between change in weight (in kg) or body mass index (BMI) with overall and CRC-specific survival were estimated using Cox regression analysis adjusted for age, sex, American Joint Committee on Cancer stage of disease, baseline BMI, nonsteroidal anti-inflammatory drug use, smoking, time between diagnosis and enrollment, and study site. RESULTS: At the 5-year postdiagnostic survey, 2049 participants reported higher (53%; median plus 5 kg), unchanged (12%), or lower (35%; median -4 kg) weight. Over a median of 5.1 years of subsequent follow-up (range, 0.3-9.9 years), 344 participants died (91 of CRC). Long-term weight loss (per 5 kg) was found to be associated with poorer overall survival (hazard ratio, 1.13; 95% confidence interval, 1.07-1.21) and CRC-specific survival (hazard ratio, 1.25; 95% confidence interval, 1.13-1.39). Significantly lower survival was similarly observed for relative weight loss (>5% vs 5% change), BMI reduction (per 1 unit), or BMI category change (overweight to normal vs remaining overweight). CONCLUSIONS: Weight loss 5 years after a diagnosis of CRC was found to be significantly associated with decreased long-term survival, suggesting the importance of avoiding weight loss in survivors of CRC. Future research should attempt to further evaluate this association, accounting for whether this weight change was intentional or represents a marker of declining health. Cancer 2017;123:4701-8.
INTRODUCTION
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer death worldwide. 1 Improvements in CRC screening and treatment have contributed to a growing population of survivors of CRC. 2 As such, efforts to identify modifiable behaviors and risk factors associated with CRC survival are of increasing clinical 3, 4 and public health 5, 6 importance. Body mass index (BMI) has been associated with both the risk of developing CRC [7] [8] [9] [10] [11] and survival after CRC diagnosis. [12] [13] [14] [15] [16] The majority of prior studies have relied on measurements of BMI taken at a single time point either before, at, or after CRC diagnosis, 14 the timing of which may be important for prognosis. 12 Because weight loss is a common side effect of CRC, longitudinal studies of weight change over time may provide a more complete picture of how body weight is associated with cancer survival.
Growing evidence suggests that weight gain is associated with an increased risk of CRC. 17, 18 To the best of our knowledge, fewer studies have evaluated adult weight change as it relates to CRC survival, 12, 13, [19] [20] [21] [22] but have suggested that postdiagnostic weight loss may be associated with lower survival. These studies have differed with regard to the duration of the time interval over which weight change is measured and the relation of the timing of weight measurements to time of diagnosis, and have focused on weight change in the 6 months to 24 months immediately after diagnosis. To our knowledge, no study has investigated long-term postdiagnostic weight change as it relates to CRC survival.
We investigated whether long-term weight change, rather than absolute weight/BMI, in the 5-year period after CRC diagnosis was associated with long-term survival.
MATERIALS AND METHODS

Study Participants
The Colon Cancer Family Registry (CCFR) is an international consortium focused on CRC research. 23, 24 This study included data from 4 population-based CCFR study sites: Cancer Care Ontario/Lunenfeld-Tanenbaum Research Institute (Toronto, Ontario, Canada), Fred Hutchinson Cancer Research Center (Seattle, Washington), Mayo Clinic (Rochester, Minnesota), and the University of Melbourne (Melbourne, Victoria, Australia).
Details of the CCFR have been described previously, 13, [24] [25] [26] [27] [28] and are available online. 23 Briefly, incident CRC cases diagnosed from 1997 through 2008 were identified through population-based cancer registries. Enrolled participants completed questionnaires at baseline and at 5-year intervals. Local study approval was provided by the Institutional Review Boards at each study center, and all participants provided written informed consent.
Only participants who completed both the baseline and the 5-year postdiagnosis follow-up questionnaire were included in the current analysis. Of these 3001 cases, we excluded those whose baseline survey was completed >2 years after diagnosis (283 participants); those whose follow-up survey was completed >6 years after enrollment (245 participants); those with <3 months of follow-up after the follow-up survey (410 participants); and participants with missing information regarding weight (212 participants), height (16 participants), smoking status (8 participants), or nonsteroidal anti-inflammatory drug (NSAID) use (48 participants). Thus, data regarding 2049 participants remained for analyses.
Data Collection
Participants completed a structured telephone interview or self-administered questionnaire at a median of 9 months (range, 0-24 months) after diagnosis ( Fig. 1) , in which they self-reported demographic, epidemiologic, and dietary characteristics 2 years prior. These responses thus correspond to participant characteristics at a median of 15.0 months (range, 1-24 months) before diagnosis. Participants were actively followed via periodic contact, and completed follow-up questionnaires at a median of 4.9 years (range, 3.5-6.0 years) after enrollment (ie, median of 5.9 years after CRC diagnosis).
Cancer stage at the time of diagnosis was derived from information regarding TNM stage and Surveillance, Epidemiology, and End Results summary stage into American Joint Committee on Cancer stages I to IV. 29 Followup for vital status and cause of death was completed through periodic linkage to population-based registries, contact with relatives, and the collection of death certificates. Vital status information was available through June 2014. International Classification of Diseases 10th Revision (ICD-10) codes retrieved from death records were used to classify whether deaths were due to CRC (codes C18.0, C18.2-C20.9, or C26.0) or any other cause. 30 
Data Definitions and Statistical Analyses
Participants self-reported height and weight at baseline (weight 2 years prior) and at the 5-year follow-up (current weight). 24 Change in weight was calculated by subtracting weight at the 5-year follow-up from baseline weight. Relative weight change was calculated as weight change divided by weight at baseline, multiplied by 100. Delayed-entry Cox regression models were used to estimate the hazard ratio (HR) and 95% confidence interval (95% CI) for the association between weight change and overall or CRC-specific survival. Survival time was calculated starting at the date of the 5-year follow-up survey and ending at either death or the date of last followup. Models adjusted for the following potential confounders 32 : age at the time of diagnosis, sex, smoking history, NSAID use, American Joint Committee on Cancer stage at the time of diagnosis, days between diagnosis and baseline survey, and baseline BMI category. To more fully capture potential associations with survival, associations with weight change were assessed for several continuous and categorical parameterizations: linear weight change (per 5 kg); linear BMI change (per 1 kg/m 2 ); categorical weight change (gained >2 kg or lost >2 kg vs kg, or lost >2 kg, vs 2-kg difference); and categorical relative weight change (gained >5% or lost >5% vs 5%, or lost >5%, vs 5% difference). Additional analyses examined categorical BMI change (moved into a higher BMI category or lower BMI category vs no change). Proportional hazards assumptions were verified by testing for a nonzero slope of the scaled Schoenfeld residuals on ranked failure times. 33 All P values were 2-sided, with P <.05 denoting statistical significance. Analyses were performed using Stata statistical software (version 14; StataCorp LLC, College Station, Texas). 34 
RESULTS
Among the 2049 individuals included in the analytic data set, 344 died (91 from CRC) over a median of 5.1 years of follow-up (range, 0.3-9.9 years) after the 5-year follow-up survey. Participant characteristics are presented in Table  1 , both overall and by category of relative weight change (>5% loss, 5% change, or >5% gain). At the time of follow-up, 1090 participants (53%) had gained weight (median, 15 kg), 244 (12%) reported the same weight, and 715 (35%) had lost weight (median -4 kg). The majority of participants (72%) were in the same BMI category at both time points (Table 2) . Weight loss was consistently associated with lower survival (Table 3) . Modeled continuously, weight loss (per 5 kg) after CRC diagnosis was found to be significantly associated with lower overall survival (HR, 1.13; 95% CI, 1.07-1.21) and CRC-specific survival (HR, 1.25; 95% CI, 1. Moving from overweight to normal BMI over the postdiagnosis period (vs overweight at both time points) was found to be significantly associated with a lower overall survival (HR, 3.67; 95% CI, 2.41-5.60) and CRC-specific survival (HR, 6.68; 95% CI, 3.06-14.55) ( Table 4) . Moving from obese to overweight also was associated with lower overall survival (HR, 1.69; 95% CI, 1.00-2.85).
Several post hoc exploratory analyses were performed to explore these associations further. Sensitivity analyses excluding those individuals with stage IV CRC, those who were missing stage information, or both did not substantially alter the results shown in Table 3 or  Table 4 (see Supporting Information Table 1 ). In sensitivity analyses of continuous weight change stratified by BMI category at baseline, weight loss remained statistically significant among those who were overweight and obese at baseline for overall survival, and among those Original Article overweight at baseline for CRC-specific survival (see Supporting Information Table 2 ). In sensitivity analyses of categorical weight change stratified by BMI category at baseline, the associations between a loss of either >5% or >2 kg of body weight and survival remained statistically significant among those of normal or overweight, but not obese, BMI at baseline. Additional exploratory analyses evaluated participant sex or stage of disease at the time of diagnosis as potential effect modifiers of the association between weight change and survival. Likelihood ratio tests of nested models containing interaction terms with weight change were not found to be statistically significant for stage of disease at the time of diagnosis, but suggested a potential difference by sex for CRC-specific survival (see Supporting Information Table 3 ). In sex-stratified analyses, associations between weight loss and survival had larger effect sizes and remained statistically significant in males, but had reduced effect sizes and were not statistically significant in females.
DISCUSSION
Weight loss in the approximately 5-year period after CRC diagnosis was found to be significantly associated with lower overall and CRC-specific survival. This association was consistently observed regardless of whether weight loss was modeled continuously or categorically, or in relative or absolute terms. These findings support the importance of weight loss as a potential indicator of declining health in cancer survivors, even years after diagnosis.
Emerging evidence suggest a J-shaped association between body weight and CRC survival, in which overweight survivors of CRC may have the lowest risk of mortality. 16, 35, 36 This relationship may vary by cancer stage, with a higher BMI associated with lower survival for patients with early-stage CRC but higher survival for those with later-stage CRC. 15 Meta-analyses of clinical trials have suggested that underweight and obese (but not overweight) BMI may be detrimental for patients with stage II to stage III CRC, 37 and that lower BMI (<28 kg/m 2 ) may be detrimental for patients with stage IV CRC. 38 The timing of weight assessment in relation to diagnosis appears important when considering prognosis, with prediagnostic BMI perhaps more informative for prognosis than postdiagnostic BMI. 12 However, the majority of previous research has used static BMI measurements to evaluate the association between body weight and survival. Because weight often changes over time, there is a recognized need to investigate the impact of weight change in cancer survivors. 3, 39, 40 Weight loss related to CRC symptoms and treatment is common, and may negatively impact subsequent survival. Previous studies have demonstrated that weight control is important for CRC survivorship, observing lower survival with prediagnostic weight gain, 13 prediagnosis to postdiagnosis weight loss, 12, 21 and short-term postdiagnostic weight loss. 20, 22 Although an early study reported no association with short-term postdiagnostic weight change, 19 a recent meta-analysis suggested that weight maintenance after diagnosis may be advantageous for cancer survivors who are overweight after diagnosis. 35 Notably, these previous studies generally have evaluated shorter time intervals for weight change after diagnosis (1-2 years), and have had near-term periods of follow-up (up to 5 years). To the best of our knowledge, the current study is the first to evaluate the association of long-term (4-6 years) weight change after CRC diagnosis with subsequent long-term (>5 years) survival. Consistent with studies of short-term weight changes, we observed that weight loss was associated with lower survival, and that weight maintenance may be beneficial even if a patient initially is overweight. Notably, these findings are in conflict with current survivorship guidelines, which recommend that patients obtain and maintain a normal weight. 36, 41 This conflict is particularly striking because the current study findings relate to long-term weight change 4 to 6 years after diagnosis, when a cancer survivor is likely moving past the period of active cancer treatment. Although CRC-related issues and symptoms are most prominent during the first 3 years after diagnosis, long-term effects can persist. 42 More research is needed to identify whether additional factors, such as long-term effects or metabolic dysfunction, may contribute to the observed lower survival after weight loss.
Associations of postdiagnostic weight loss with lower survival have been reported in several other cancer types, 43 including breast, 44, 45 endometrial, 46 lung, 47 prostate, 48 and esophageal cancer. 49 Involuntary weight and muscle loss leading to cachexia and sarcopenia, respectively, are common in patients with cancer and are indicators of poor prognosis. 3, 20, 50 Together, these results suggest the importance of avoiding weight loss after diagnosis, and may point toward weight maintenance as a prudent goal for survivors of some cancers. 44 Potential biological rationales for better survival with higher weight in cancer survivors include extra nutritional reserves, greater muscle mass, a lower likelihood of dose-limiting toxicity, or potentially less aggressive tumors. 3, 51, 52 BMI is a crude measure of adiposity, and does not capture differences in body composition (muscle vs fat) or fat distribution (subcutaneous vs visceral). 53 These differences also vary by sex, with females generally carrying proportionately more body fat and males having more central adiposity, 54 which may be contributing to the differential associations of weight loss and survival observed in the sex-stratified exploratory analyses. Body habitus also is likely influenced by many factors that change over time, both lifestyle (caloric intake, diet, physical activity, etc) and medical (access to medical care, treatments, comorbidities, adverse events, and late effects). As such, it is difficult to determine the proportional contribution of weight change to long-term survival. We were unable to determine whether the weight loss reported in the current study was intentional (eg, through diet and/or exercise) or unintentional (eg, as a result of cachexia or sarcopenia). Given that unintentional weight loss likely relates to treatment effects or disease progression/recurrence, and could be a general marker of declining health, this limitation should be considered before encouraging clinical implementation of the current study findings.
We were unable to evaluate how diet and exercise may have contributed to energy balance and weight change. Exercise may be particularly important in cancer survivors because weight loss independent of exercise may promote sarcopenia or loss of lean mass, 36, 55 and increased physical activity after a diagnosis of CRC is associated with improved survival. 56, 57 Guidelines for weight management in adults recommend a 3-pronged approach of dietary energy restriction, regular physical activity, and behavioral modification. 58 Additional investigation is needed to identify how these factors influence weight change in survivors of CRC, and to determine how sarcopenia or cachexia may be involved in the observed association with survival.
The current study has several limitations. The results are based on long-term changes in weight among participants who survived 5 years after their diagnosis. This inherent survival bias meant that the sample in the current study comprised proportionately more participants who were younger, had an early-stage cancer at the time of diagnosis, and likely had fewer comorbidities, thereby potentially limiting the generalizability of the findings of the current study. Another limitation is that body weight was self-reported at each time point, perhaps resulting in measurement error with regard to weight change. However, questionnaire-based body weight recall tends to be fairly accurate. 59 Participants also are likely to have internal consistency in their reporting, such that changes in weight may be less prone to such bias than individual weight measurements. Finally, participants may have experienced large fluctuations in weight during the postdiagnosis period that would not have been captured by our surveys. Although we included established and suspected factors that might confound the relationship under study, there nonetheless may be other unmeasured confounding factors influencing these findings, such as participants' area of residence or access to treatment. 60 Future studies with longer and more frequent follow-up of participants who develop CRC are needed to evaluate how the pace, trajectory, or pattern of weight change may affect the association between body weight and CRC survival.
Original Article
The current study has several strengths that improve confidence in its results. These include a large sample size, long follow-up time, well-characterized outcomes, and detailed information regarding both the primary exposure and potential confounders. Another major strength is the population-based design, which allows for an estimate of the association between weight change and CRC survival that is more likely to be generalizable. The current study findings also are consistent with findings from shorter-term studies, and warrant replication and exploration in larger and more frequently characterized study populations. Exploratory analyses suggesting that these associations may be particularly relevant for males and those who are overweight at the time of diagnosis also warrant future investigation.
Conclusions
The findings of the current study suggest the importance of avoiding weight loss among long-term survivors of CRC, even among those who are overweight or obese. This conflicts with current recommendations to achieve and maintain a normal weight. Patients and physicians should be aware of the potential decreased survival among those patients who experience weight loss after CRC, even many years after diagnosis. Additional research is warranted to evaluate the additional contribution of diet, physical activity, and body composition for CRC survival within the context of weight change after diagnosis.
FUNDING SUPPORT
